Drugs / sorafenib (200 or 400mg bid) and taxotere iv
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT00405210 Background | Sep 2006 → Aug 2008 | prostate cancer | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | sorafenib (200 or 400mg bid) and taxotere iv | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00405210 ↗ |